The goals of the University of Chicago Cancer Research Center Animal Barrier Facility are multifold. The Facility provides to any investigator the means to perform animal studies using specific pathogen-free mice and rats. In addition, the Facility provides expertise in viral analyses of biological materials that are introduced into the animals and is capable of performing laboratory analyses of mice maintained in the facility. The Animal Barrier Facility in FMI is an essential component of the Cancer Research Center, providing a quality barrier facility (approximately 6,800 sq ft) to investigators requiring mice free from adventitious agents. The Facility contains seven animal rooms each equipped with three Illinois cabinets capable of housing approximately 1,260 cages or 5,040 adult mice (single shelved). These animal rooms, along with a laboratory, a procedure room and a dedicated pass through cage washing and autoclave area, are situated within a supply and return corridor system. Pass-through lockers with shower facilities are used to access the supply corridor and clean service areas. An office and support areas for feed, bedding and storage complement the Facility. Elevator access is limited, and a separate delivery deck is used to accept mice to be housed in this Facility. Microisolator caging systems are employed throughout the barrier. All cages along with bedding are autoclaved prior to entry into a room. Animals are transferred within a separate hood or within the Illinois cabinet by the animal care staff, using chemically treated forceps between cage transfers. A maximum of four adult mice are permitted per cage, and cages are changed twice weekly. Colony animals are maintained in """"""""red rooms"""""""" which are entered only by animal care staff. these animals are brought to experimental rooms by animal care staff on request. A bar coded entry computer system provides accurate and detailed census information on a weekly basis when requested by investigators. The quality control and preventive medical programs are overseen through the veterinary faculty. The health quality control program is designed to detect statistical variances from established norms at specific infectious disease prevalence levels and at specific time intervals. This program employs sentinel animals monitored monthly and quarterly, serum banking, evaluation of """"""""index"""""""" cases and close communications with investigators who may note unexplained variances in their experiments.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014599-19
Application #
3793274
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
19
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Trujillo, Jonathan A; Sweis, Randy F; Bao, Riyue et al. (2018) T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection. Cancer Immunol Res 6:990-1000
Zeng, Zongyue; Huang, Bo; Huang, Shifeng et al. (2018) The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs. Genes Dis 5:62-74
Lee, Ji-Hye; Park, Beom Seok; Han, Kang R et al. (2018) Insight Into the Interaction Between RNA Polymerase and VPg for Murine Norovirus Replication. Front Microbiol 9:1466
Cheng, Jason X; Chen, Li; Li, Yuan et al. (2018) RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun 9:1163
Johnson, Marianna B; Hoffmann, Joscelyn N; You, Hannah M et al. (2018) Psychosocial Stress Exposure Disrupts Mammary Gland Development. J Mammary Gland Biol Neoplasia 23:59-73
Sweis, Randy F; Zha, Yuanyuan; Pass, Lomax et al. (2018) Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer. J Immunother Cancer 6:24
Kathayat, Rahul S; Cao, Yang; Elvira, Pablo D et al. (2018) Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes. Nat Commun 9:334
Liu, Jun; Eckert, Mark A; Harada, Bryan T et al. (2018) m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol 20:1074-1083
Bhanvadia, Raj R; VanOpstall, Calvin; Brechka, Hannah et al. (2018) MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Clin Cancer Res 24:3668-3680
Wood, Kevin; Byron, Elizabeth; Janisch, Linda et al. (2018) Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol 41:963-966

Showing the most recent 10 out of 668 publications